Τίτλος:
Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Approximately half a century has passed since the discovery of beta-blockers. Then, their prime therapeutic purpose was to treat angina and cardiac arrhythmias; nowadays, beta-blockers’ usage and effectiveness are extended to treat other cardiovascular diseases, such as hypertension, congestive heart failure, and coronary artery disease. Safety concerns were raised about beta-blockers and their use for chronic obstructive pulmonary disease (COPD) patients with concurrent cardiovascular disease. After thorough research of the literature, this review summarizes the evidence proving that beta-blockers not only might be well tolerated in COPD patients, but they might also have a beneficial effect in this group of patients. © 2021 Bentham Science Publishers.
Συγγραφείς:
Baou, K.
Katsi, V.
Makris, T.
Tousoulis, D.
Περιοδικό:
Current Hypertension Reviews
Εκδότης:
Bentham Science Publishers
Λέξεις-κλειδιά:
acebutolol; atenolol; beta adrenergic receptor blocking agent; betaxolol; bisoprolol fumarate; carvedilol; esmolol; labetalol; metoprolol; nadolol; nebivolol; penbutolol; pindolol; propranolol; sotalol; timolol; beta adrenergic receptor blocking agent, all cause mortality; angina pectoris; atrial fibrillation; cardiovascular disease; cardiovascular mortality; chronic obstructive lung disease; coronary artery bypass graft; forced expiratory volume; heart failure; heart infarction; heart ventricle arrhythmia; hypertension; lung disease; lung function; migraine; respiratory tract disease; Review; cardiovascular disease; chronic obstructive lung disease; heart arrhythmia; heart failure; human, Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiovascular Diseases; Heart Failure; Humans; Pulmonary Disease, Chronic Obstructive
DOI:
10.2174/1573402116999201209203250
